Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction

Growth Hormone and IGF Research

Volumn 21, Issue 1, 2011, Pages 31-36

  Koutsaki, Maria ^a   Sifakis, Stavros ^b   Zaravinos, Apostolos ^a   Koutroulakis, Dimitrios ^b   Koukoura, Ourania ^b   Spandidos, Demetrios A ^a  

^a UNIVERSITY OF CRETE   (Greece)

^b UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

Author keywords

Fetal growth; Fetal growth restriction; Human Placental Growth Hormone; IGF binding Protein 1; IGF binding Protein 3; Insulin like Growth Factor I

Indexed keywords

HORMONE; PLACENTAL GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FETUS; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MALE; NEWBORN; PATHOGENESIS; PLACENTA; PREGNANCY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; DOWN-REGULATION; FEMALE; FETAL GROWTH RETARDATION; GENE EXPRESSION REGULATION; HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR I; PLACENTA; PLACENTAL HORMONES; PREGNANCY; YOUNG ADULT;

EID: 79951720746     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2010.12.002     Document Type: Article

References (55)

1. Romo A., Carceller R., Tobajas J. Intrauterine growth retardation (IUGR): epidemiology and etiology. Pediatr. Endocrinol. Rev. 2009, 6:332-336.
2. Pallotto E.K., Kilbride H.W. Perinatal outcome and later implications of intrauterine growth restriction. Clin. Obstet. Gynecol. 2006, 49:257-269.
3. Chellakooty M., Vangsgaard K., Larsen T., Scheike T., Falck-Larsen J., Legarth J., et al. A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: association between placental GH and fetal growth. J. Clin. Endocrinol. Metab. 2004, 89:384-391.
4. Lacroix M.C., Guibourdenche J., Frendo J.L., Muller F., Evain-Brion D. Human placental growth hormone - a review. Placenta 2002, 23:S87-S94.
5. Fuglsang J., Ovesen P. Aspects of placental growth hormone physiology. Growth Horm. IGF Res. 2006, 16:67-85.
6. Randhawa R., Cohen P. The role of the insulin-like growth factor system in prenatal growth. Mol. Genet. Metab. 2005, 86:84-90.
7. Frankenne F., Scippo M.L., Van Beeumen J., Igout A., Hennen G. Identification of placental human growth hormone as the growth hormone-V gene expression product. J. Clin. Endocrinol. Metab. 1990, 7:15-18.
8. Frankenne F., Rentier-Delrue F., Scippo M.L., Martial J., Hennen G. Expression of the growth hormone variant gene in human placenta. J. Clin. Endocrinol. Metab. 1987, 64:635-637.
9. Papadopoulou E., Sifakis S., Giahnakis E., et al. Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia. Growth Horm. IGF Res. 2006, 16:290-296.
10. Mittal P., Espinoza J., Hassan S., et al. Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. J. Matern. Fetal. Neonatal Med. 2007, 20:651-659.
11. Sifakis S., Papadopoulou E., Konstantinidou A., et al. Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome. Growth Horm. IGF Res. 2009, 19:121-125.
12. Caufriez A., Frankenne F., Hennen G., Copinschi G. Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am. J. Physiol. Endocrinol. Metab. 1993, 265:E572-E577.
13. Frankenne F., Alsat E., Scippo M.L., Igout A., Hennen G., Evain-Brion D. Evidence for the expression of growth hormone receptors in human placenta. Biochem. Biophys. Res. Commun. 1992, 182:481-486.
14. Rechler M.M., Clemmons D.R. Regulatory actions of insulin-like growth factor-binding proteins. Trends Endocrinol. Metab. 1998, 9:176-183.
15. Monzavi R., Cohen P. IGFs and IGFBPs: role in health and disease. Best Pract. Res. Clin. Endocrinol. Metab. 2002, 16:433-447.
16. Lee P.D., Giudice L.C., Conover C.A., Powell D.R. Insulin-like growth factor binding protein-1: recent findings and new directions. Proc. Soc. Exp. Biol. Med. 1997, 216:319-357.
17. Lassarre C., Hardouin S., Daffos F., Forestier F., Frankenne F., Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in subjects with intrauterine growth retardation. Pediatr. Res. 1991, 29:219-225.
18. Mirlesse V., Frankenne F., Alsat E., Pounchelet M., Hennen G., Evain-Brion D. Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr. Res. 1993, 34:439-442.
19. Langford K., Blum W., Nicolaides K., Jones J., McGregor A., Miell J. The pathophysiology of the insulin-like growth factor axis in fetal growth failure: a basis for programming by under nutrition?. Eur. J. Clin. Invest. 1994, 24:851-856.
20. Giudice L.C., de Zegher F., Gargosky S.E., et al. Insulin-like growth factors and their binding proteins in the term and pre-term human fetus and neonate with normal and extremes of intrauterine growth. J. Clin. Endocrinol. Metab. 1995, 80:1548-1555.
21. Langford K.S., Nicolaides K.H., Jones J., Abbas A., McGregor A.M., Miell J.P. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal and multiple human pregnancy. J. Clin. Endocrinol. Metab. 1995, 80:21-27.
22. Spencer J.A., Chang T.C., Jones J., Robson S.C., Preece M.A. Third trimester fetal growth and umbilical venous blood concentrations of IGF-I, IGFBP-1 and growth hormone at term. Arch. Dis. Child. Fetal Neonatal Ed. 1995, 73:F87-F90.
23. Leger J., Oury J.F., Noel M., et al. Growth factors and intrauterine growth retardation. I. Serum growth hormone, insulin-like growth factor (IGF)-I, IGF-II, and IGF binding protein 3 levels in normally grown and growth-retarded human fetuses during the second half of gestation. Pediatr. Res. 1996, 40:94-100.
24. Holmes R., Montemagno R., Jones J., Preece M., Rodeck C., Soothill P. Fetal and maternal plasma insulin-like growth factors and binding proteins in pregnancies with appropriate or retarded fetal growth. Early Hum. Dev. 1997, 49:7-17.
25. McIntyre H.D., Serek R., Crane D.L., et al. Placental growth hormone (GH), GH-Binding Protein and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth. J. Clin. Endocrinol. Metab. 2000, 85:1143-1150.
26. Street M.E., Seghini P., Fieni S., et al. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur. J. Endocrinol. 2006, 155:567-574.
27. Verkauskiene R., Beltrand J., Claris O., et al. Impact of fetal growth restriction on body composition and hormonal status at birth in infants of small and appropriate weight for gestational age. Eur. J. Endocrinol. 2007, 157:605-612.
28. Gardosi J., Francis A. Software program for the calculation of customized birth weight percentiles 15 April, 2010, Version 6.2, 2000-2007, Available at: http://www.gestation.net. Retrieved.
29. Zaravinos A., Bizakis J., Spandidos D.A. RKIP and BRAF aberrations in human nasal polyps and the adjacent turbinate mucosae. Cancer Lett. 2008, 264:288-298.
30. Abu-Amero S.N., Ali Z., Bennett P., Vaughan J.I., Moore G.E. Expression of the insulin-like growth factors and their receptors in term placentas: a comparison between normal and IUGR births. Mol. Reprod. Dev. 1998, 49:229-235.
31. Calvo M.T., Romo A., Gutiérrez J.J., Relaño E., Barrio E., Ferrández Longás A. Study of genetic expression of intrauterine growth factors IGF-I and EGFR in placental tissue from pregnancies with intrauterine growth retardation. J. Pediatr. Endocrinol. Metab. 2004, 17:445-450.
32. Okamoto A., Endo H., Kalionis B., et al. IGFBP1 and Follistatin-like 3 genes are significantly up-regulated in expression profiles of the IUGR placenta. Placenta 2006, 27:317-321.
33. Trollmann R., Klingmüller K., Schild R.L., Rascher W., Dötsch J. Differential gene expression of somatotrophic and growth factors in response to in vivo hypoxia in human placenta. Am. J. Obstet. Gynecol. 2007, 197:601.e1-601.e6.
34. Barrio E., Calvo M.T., Miramar M.D., et al. Study of apoptosis and related proteins, CRH and hpGH in placentas of newborns small for gestational age (SGA). Pediatr. Endocrinol. Rev. 2009, 6:337-342.
35. Struwe E., Berzl G., Schild R., et al. Microarray analysis of placental tissue in intrauterine growth restriction. Clin. Endocrinol. (Oxf) 2010, 72(2):241-247.
36. Tzschoppe A., Struwe E., Blessing H., et al. Placental 11beta-HSD2 gene expression at birth is inversely correlated with growth velocity in the first year of life after intrauterine growth restriction. Pediatr. Res. 2009, 65:647-653.
37. Sheikh S., Satoskar P., Bhartiya D. Expression of insulin-like growth factor-1 and placental growth hormone mRNA in placentae: a comparison between normal and intrauterine growth retardation pregnancies. Mol. Hum. Reprod. 2001, 7:287-292.
38. Dalçik H., Yardimoǧlu M., Vural B., et al. Expression of insulin-like growth factor in the placenta of intrauterine growth-retarded human fetuses. Acta Histochem. 2001, 103:195-207.
39. Ozkan S., Vural B., Dalçik C., Taş A., Dalçik H. Placental expression of insulin-like growth factor-I, fibroblast growth factor-basic and neural cell adhesion molecule in pregnancies with small for gestational age fetuses. J. Perinatol. 2008, 28:468-474.
40. Chowen J.A., Evain-Brion D., Pozo J., Alsat E., García-Segura L.M., Argente J. Decreased expression of placental growth hormone in intrauterine growth retardation. Pediatr. Res. 1996, 39:736-739.
41. Wang H.S., Lim J., English J., Irvine L., Chard T. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J. Endocrinol. 1991, 129:459-464.
42. Tzschoppe A.A., Struwe E., Dörr H.G., et al. Differences in gene expression dependent on sampling site in placental tissue of fetuses with intrauterine growth restriction. Placenta 2010, 31(3):178-185.
43. Brizot M.L., Jauniaux E., Mckie A.T., Farzaneh F., Nicolaides K.H. Placental expression of alpha and beta subunits of human chorionic gonadotrophin in early pregnancies with Down's syndrome. Hum. Reprod. 1995, 10:2506-2509.
44. Brizot M.L., Hyett J.A., Mckie A.T., Bersinger N.A., Farzaneh F., Nicolaides K.H. Gene expression of human pregnancy-associated plasma protein-A in placenta from trisomic pregnancies. Placenta 1996, 17:33-36.
45. Spencer K., Yu C.K., Savvidou M., Papageorghiou A.T., Nicolaides K.H. Prediction of pre-eclampsia by uterine artery Doppler ultrasonography and maternal serum pregnancy-associated plasma protein-A, free beta-human chorionic gonadotropin, activin A and inhibin A at 22+0 to 24+6weeks' gestation. Ultrasound Obstet. Gynecol. 2006, 27:658-663.
46. Juul A., Kastrup K.W., Pedersen S.A., Skakkebaek N.E. Growth hormone (GH) provocative retesting of 108 young adults with childhood-onset GH deficiency and the diagnostic value of insulin-like growth factor I (IGF-I) and IGF-binding protein-3. J. Clin. Endcorinol. Metab. 1997, 82:1195-1201.
47. Street M.E., Seghini P., Ziveri M.A., et al. Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation. Growth Horm. IGF Res. 2006, 16:365-372.
48. Hills F.A., Gunn L.K., Hardiman P., Thamaratnam S., Chard T. IGFBP-1 in the placenta, membranes and fetal circulation: levels at term and preterm delivery. Early Hum. Dev. 1996, 44:71-76.
49. Kekki M., Kurki T., Kärkkäinen T., Hiilesmaa V., Paavonen J., Rutanen E.M. Insulin-like growth factor-binding protein-1 in cervical secretion as a predictor of preterm delivery. Acta Obstet. Gynecol. Scand. 2001, 80:546-551.
50. Tanir H.M., Sener T., Yildiz Z. Cervical phosphorylated insulin-like growth factor binding protein-1 for the prediction of preterm delivery in symptomatic cases with intact membranes. J. Obstet. Gynaecol. Res. 2009, 35:66-72.
51. Lee S.E., Han B.D., Park I.S., Romero R., Yoon B.H. Evidence supporting proteolytic cleavage of insulin-like growth factor binding protein-1 (IGFBP-1) protein in amniotic fluid. J. Perinat. Med. 2008, 36:316-323.
52. Cooley S.M., Donnelly J.C., Collins C., Geary M.P., Rodeck C.H., Hindmarsh P.C. The relationship between maternal insulin-like growth factors 1 and 2 (IGF-1, IGF-2) and IGFBP-3 to gestational age and preterm delivery. J. Perinat. Med. 2010, 38:255-259.
53. Fuglsang J., Sandager P., Møller N., Fisker S., Orskov H., Ovesen P. Kinetics and secretion of placental growth hormone around parturition. Eur. J. Endocrinol. 2006, 154:449-457.
54. Mittal P., Hassan S.S., Espinoza J., et al. The effect of gestational age and labor on placental growth hormone in amniotic fluid. Growth Horm. IGF Res. 2008, 18:174-179.
55. Sitras V., Paulssen R.H., Grønaas H., Vårtun A., Acharya G. Gene expression profile in labouring and non-labouring human placenta near term. Mol. Hum. Reprod. 2008, 14:61-65.